Central GABAergic mechanisms are defective in salt-induced hypertension in borderline hypertensive rats. 1995

M Momohara, and T Imaizumi, and T Endo, and S Suzuki, and T Tagawa, and M Shiramoto, and H Masaki, and A Takeshita
Research Institute of Angiocardiology and Cardiovascular Clinic, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

We examined the role of central GABAergic mechanisms in salt-induced hypertension and exaggerated responses to stress in borderline hypertensive rats (BHR), the first offspring of spontaneously hypertensive rats (SHR) and Wistar-Kyoto rats (WKY). The studies were done in conscious BHR and WKY on high (H) (8% NaCl) or normal (N) (0.3% NaCl) salt diets for 5 weeks. A high-salt diet elevated arterial pressure (AP) (p < 0.01) and augmented pressor responses to shaker stress (p < 0.05) in BHR but not in WKY. Intravenous hexamethonium caused a greater decrease in AP in BHR-H than in BHR-N at rest. Muscimol (a GABA agonist) injected into the central ventricle (i.c.v.) caused a greater decrease in resting AP (p < 0.01) and heart rate (HR) (p < 0.05) and BHR-H than in BHR-N. Renal sympathetic nerve activity (RSNA) did not change in BHR-H, but increased (p < 0.05) in BHR-N during muscimol-induced hypotension, although the magnitudes of muscimol-induced hypotension were greater in BHR-N than in BHR-N. The increases in RSNA in response to intravenous nitroglycerin were similar in BHR-N and BHR-N. Muscimol attenuated pressor and tachycardic responses to stress more in BHR-N than in BHR-N (p < 0.01). Muscimol did not alter AP and HR at rest or their responses to stress in the two groups of WKY. The magnitudes of pressor response to bicuculline (a GABA antagonist) did not differ between the two groups of BHR. These results suggest that a high salt diet may alter the central GABAergic system in BHR, which contributes to salt-induced hypertension and augmented pressor and tachycardic responses to stress.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007276 Injections, Intraventricular Injections into the cerebral ventricles. Intraventricular Injections,Injection, Intraventricular,Intraventricular Injection
D008297 Male Males
D009118 Muscimol A neurotoxic isoxazole isolated from species of AMANITA. It is obtained by decarboxylation of IBOTENIC ACID. Muscimol is a potent agonist of GABA-A RECEPTORS and is used mainly as an experimental tool in animal and tissue studies. Agarin,Pantherine
D010656 Phenylephrine An alpha-1 adrenergic agonist used as a mydriatic, nasal decongestant, and cardiotonic agent. (R)-3-Hydroxy-alpha-((methylamino)methyl)benzenemethanol,Metaoxedrin,Metasympatol,Mezaton,Neo-Synephrine,Neosynephrine,Phenylephrine Hydrochloride,Phenylephrine Tannate,Neo Synephrine,Tannate, Phenylephrine
D011918 Rats, Inbred SHR A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. Rats, Spontaneously Hypertensive,Rats, SHR,Inbred SHR Rat,Inbred SHR Rats,Rat, Inbred SHR,Rat, SHR,Rat, Spontaneously Hypertensive,SHR Rat,SHR Rat, Inbred,SHR Rats,SHR Rats, Inbred,Spontaneously Hypertensive Rat,Spontaneously Hypertensive Rats
D011921 Rats, Inbred WKY A strain of Rattus norvegicus used as a normotensive control for the spontaneous hypertensive rats (SHR). Rats, Wistar Kyoto,Wistar Kyoto Rat,Rats, WKY,Inbred WKY Rat,Inbred WKY Rats,Kyoto Rat, Wistar,Rat, Inbred WKY,Rat, WKY,Rat, Wistar Kyoto,WKY Rat,WKY Rat, Inbred,WKY Rats,WKY Rats, Inbred,Wistar Kyoto Rats
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003243 Consciousness Sense of awareness of self and of the environment. Consciousnesses
D005680 gamma-Aminobutyric Acid The most common inhibitory neurotransmitter in the central nervous system. 4-Aminobutyric Acid,GABA,4-Aminobutanoic Acid,Aminalon,Aminalone,Gammalon,Lithium GABA,gamma-Aminobutyric Acid, Calcium Salt (2:1),gamma-Aminobutyric Acid, Hydrochloride,gamma-Aminobutyric Acid, Monolithium Salt,gamma-Aminobutyric Acid, Monosodium Salt,gamma-Aminobutyric Acid, Zinc Salt (2:1),4 Aminobutanoic Acid,4 Aminobutyric Acid,Acid, Hydrochloride gamma-Aminobutyric,GABA, Lithium,Hydrochloride gamma-Aminobutyric Acid,gamma Aminobutyric Acid,gamma Aminobutyric Acid, Hydrochloride,gamma Aminobutyric Acid, Monolithium Salt,gamma Aminobutyric Acid, Monosodium Salt

Related Publications

M Momohara, and T Imaizumi, and T Endo, and S Suzuki, and T Tagawa, and M Shiramoto, and H Masaki, and A Takeshita
January 1982, Clinical and experimental hypertension. Part A, Theory and practice,
M Momohara, and T Imaizumi, and T Endo, and S Suzuki, and T Tagawa, and M Shiramoto, and H Masaki, and A Takeshita
June 1994, Hypertension (Dallas, Tex. : 1979),
M Momohara, and T Imaizumi, and T Endo, and S Suzuki, and T Tagawa, and M Shiramoto, and H Masaki, and A Takeshita
January 1997, Hypertension (Dallas, Tex. : 1979),
M Momohara, and T Imaizumi, and T Endo, and S Suzuki, and T Tagawa, and M Shiramoto, and H Masaki, and A Takeshita
May 1999, Hypertension (Dallas, Tex. : 1979),
M Momohara, and T Imaizumi, and T Endo, and S Suzuki, and T Tagawa, and M Shiramoto, and H Masaki, and A Takeshita
February 1984, Journal of hypertension,
M Momohara, and T Imaizumi, and T Endo, and S Suzuki, and T Tagawa, and M Shiramoto, and H Masaki, and A Takeshita
November 1988, Japanese circulation journal,
M Momohara, and T Imaizumi, and T Endo, and S Suzuki, and T Tagawa, and M Shiramoto, and H Masaki, and A Takeshita
December 1998, Physiology & behavior,
M Momohara, and T Imaizumi, and T Endo, and S Suzuki, and T Tagawa, and M Shiramoto, and H Masaki, and A Takeshita
November 2001, American journal of hypertension,
M Momohara, and T Imaizumi, and T Endo, and S Suzuki, and T Tagawa, and M Shiramoto, and H Masaki, and A Takeshita
January 1991, Clinical and experimental hypertension. Part A, Theory and practice,
M Momohara, and T Imaizumi, and T Endo, and S Suzuki, and T Tagawa, and M Shiramoto, and H Masaki, and A Takeshita
June 1991, Hypertension (Dallas, Tex. : 1979),
Copied contents to your clipboard!